Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines
about
Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative DiseasesMicroglial Activation in the Pathogenesis of Huntington's Disease.A Coral-Derived Compound Improves Functional Recovery after Spinal Cord Injury through Its Antiapoptotic and Anti-Inflammatory Effects.Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury.Transcriptome sequencing reveals that LPS-triggered transcriptional responses in established microglia BV2 cell lines are poorly representative of primary microglia.PDE4B as a microglia target to reduce neuroinflammation.Traumatic Brain Injury and Stem Cell: Pathophysiology and Update on Recent Treatment Modalities.Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway.Astaxanthin acts via LRP-1 to inhibit inflammation and reverse lipopolysaccharide-induced M1/M2 polarization of microglial cells.Age increases reactive oxygen species production in macrophages and potentiates oxidative damage after spinal cord injury.Microglia M2A Polarization as Potential Link between Food Allergy and Autism Spectrum Disorders.Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection.MFG-E8 Selectively Inhibited Aβ-Induced Microglial M1 Polarization via NF-κB and PI3K-Akt Pathways.BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-κB and Activating PKA/CREB.Schwann Cell Transplantation Subdues the Pro-Inflammatory Innate Immune Cell Response after Spinal Cord InjurySwitching of the Microglial Activation Phenotype Is a Possible Treatment for Depression Disorder
P2860
Q33624262-7C82733D-31ED-4C58-AE59-094D86DDCEB0Q33679220-6E259FC9-D6CB-40DE-A944-71A6845225A9Q33809556-8EAFF701-FAB3-4AD3-9088-171D6B6BCEFAQ36123720-CB26F66A-DB3D-47FD-8BE9-1955DC1356FEQ36380305-C35CF4C6-6BBD-4E27-A2C7-76AB3AF44058Q37085246-08B15691-FE29-4490-841A-0C04CF06C1DAQ38796315-6A892EB2-BEB5-4941-A378-A53C0D05F77CQ40065771-35B40046-77E5-477B-A7FF-97F305A14E76Q41631913-E7323AA8-CBE3-4328-AE16-DD7B29BE21ACQ42378340-88A75A71-CB65-4936-A565-03333DA054D9Q42714359-75BDB2E6-B0A9-4080-A6C8-B69E0F8DD9C2Q47168640-ACC02C1F-B21C-4455-AD60-5AEC6E6D85EDQ48137882-6E77A284-B562-444F-BD13-2F466172F488Q51065451-2B411D9F-94FD-454F-800C-9FDDC076D5B4Q55456033-790A0F21-4974-4C9B-9FA6-2285DFBB84DCQ58697351-503050E4-17AC-4684-A1FE-0EC855FCD67CQ59136366-5CDACC8C-1CDE-4E93-AD2F-81B8FCFC8999
P2860
Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cyclic AMP is a key regulator ...... the presence of Th2 cytokines
@ast
Cyclic AMP is a key regulator ...... the presence of Th2 cytokines
@en
type
label
Cyclic AMP is a key regulator ...... the presence of Th2 cytokines
@ast
Cyclic AMP is a key regulator ...... the presence of Th2 cytokines
@en
prefLabel
Cyclic AMP is a key regulator ...... the presence of Th2 cytokines
@ast
Cyclic AMP is a key regulator ...... the presence of Th2 cytokines
@en
P2093
P2860
P1476
Cyclic AMP is a key regulator ...... the presence of Th2 cytokines
@en
P2093
Damien D Pearse
Mousumi Ghosh
P2860
P2888
P356
10.1186/S12974-015-0463-9
P577
2016-01-13T00:00:00Z
P5875
P6179
1015543219